| A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ... Nature medicine 25 (3), 454-461, 2019 | 633 | 2019 |
| PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial V Narayan, JS Barber-Rotenberg, IY Jung, SF Lacey, AJ Rech, MM Davis, ... Nature medicine 28 (4), 724-734, 2022 | 318 | 2022 |
| PET/CT imaging in cancer: current applications and future directions MD Farwell, DA Pryma, DA Mankoff Cancer 120 (22), 3433-3445, 2014 | 281 | 2014 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 226 | 2019 |
| First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting N Pandit-Taskar, MA Postow, MD Hellmann, JJ Harding, CA Barker, ... Journal of Nuclear Medicine 61 (4), 512-519, 2020 | 219 | 2020 |
| Positron emission tomography K Lameka, MD Farwell, M Ichise Handbook of clinical neurology 135, 209-227, 2016 | 163 | 2016 |
| A PET imaging agent for evaluating PARP-1 expression in ovarian cancer M Makvandi, A Pantel, L Schwartz, E Schubert, K Xu, CJ Hsieh, C Hou, ... The Journal of clinical investigation 128 (5), 2116-2126, 2018 | 136 | 2018 |
| CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody MD Farwell, RF Gamache, H Babazada, MD Hellmann, JJ Harding, ... Journal of Nuclear Medicine 63 (5), 720-726, 2022 | 112 | 2022 |
| A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours A Maity, R Mick, AC Huang, SM George, MD Farwell, JN Lukens, ... British journal of cancer 119 (10), 1200-1207, 2018 | 102 | 2018 |
| Imaging CAR T cell trafficking with eDHFR as a PET reporter gene MA Sellmyer, SA Richman, K Lohith, C Hou, CC Weng, RH Mach, ... Molecular Therapy 28 (1), 42-51, 2020 | 96 | 2020 |
| Making molecular imaging a clinical tool for precision oncology: a review DA Mankoff, MD Farwell, AS Clark, DA Pryma JAMA oncology 3 (5), 695-701, 2017 | 80 | 2017 |
| Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy L Dercle, J McGale, S Sun, A Marabelle, R Yeh, E Deutsch, FZ Mokrane, ... Journal for Immunotherapy of Cancer 10 (9), 2022 | 56 | 2022 |
| Diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiotherapy: a systematic review and meta-analysis H Li, L Deng, HX Bai, J Sun, Y Cao, Y Tao, MD Farwell, P Zhang, B Xiao, ... American Journal of Neuroradiology 39 (2), 280-288, 2018 | 56 | 2018 |
| Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor–T-cell therapy in B-cell non-Hodgkin lymphomas NN Shah, SJ Nagle, DA Torigian, MD Farwell, WT Hwang, N Frey, ... Cytotherapy 20 (12), 1415-1418, 2018 | 53 | 2018 |
| Development of companion diagnostics DA Mankoff, CE Edmonds, MD Farwell, DA Pryma Seminars in nuclear medicine 46 (1), 47-56, 2016 | 52 | 2016 |
| A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer. V Narayan, W Gladney, G Plesa, N Vapiwala, E Carpenter, SL Maude, ... Journal of Clinical Oncology 37 (7_suppl), TPS347-TPS347, 2019 | 43 | 2019 |
| Synthesis and reactions of Cp-linked phosphine complexes of rhodium L Lefort, TW Crane, MD Farwell, DM Baruch, JA Kaeuper, RJ Lachicotte, ... Organometallics 17 (18), 3889-3899, 1998 | 43 | 1998 |
| Positron emission tomography imaging of poly–(adenosine diphosphate–ribose) polymerase 1 expression in breast cancer: a nonrandomized clinical trial ES McDonald, RK Doot, AR Pantel, MD Farwell, RH Mach, KN Maxwell, ... JAMA oncology 6 (6), 921-923, 2020 | 38 | 2020 |
| Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: a systematic review and meta-analysis M Yang, J Sun, HX Bai, Y Tao, X Tang, Z Zhang, J Zhou, MD Farwell, ... Medicine 96 (19), e6676, 2017 | 38 | 2017 |
| Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74 IK Lee, E Noguera-Ortega, Z Xiao, L Todd, J Scholler, D Song, M Liousia, ... Clinical Cancer Research 28 (24), 5330-5342, 2022 | 33 | 2022 |
Robert H. MachBritton Chance Professor of RadiologyBestätigte E-Mail-Adresse bei mail.med.upenn.edu